, an active metabolite of trichloroethylene (TCE), was investigated in mice, as a part of mechanistic assessment of renal toxicity of TCE. To examine the subchronic effects of DCVC on kidney function, Balb/c male mice were administered DCVC orally and intraperitoneally once a week for 13 weeks at 1, 10 and 30 mg/kg (Main Study) and for 8 weeks at 30 mg/kg (PCR Study). At the terminal sacrifice, mice orally and intraperitoneally administered with 10 and 30 mg/kg showed significantly lower kidney weight and significantly higher blood urea nitrogen levels than the control group. Pathological examination revealed that a dose of 30 mg/kg delivered by both routes resulted in renal tubular degeneration characterized by tubular necrosis and interstitial fibrosis, and in degradation of the cortex. Degenerative changes were accompanied by the increased expression of tumor necrosis factor-α, interleukin-6 and cyclooxygenase-2 mRNAs in the kidney of mice treated with 30 mg/kg for 8 weeks. These pathohistological observations mostly corresponded to those in short-term toxicity studies on DCVC. DCVC might be a direct cause of renal toxicity, which is suggested from the aggravation in these symptoms with the dose increase.
INTRODUCTION
Trichloroethylene (TCE) is a synthetic chlorocarbon that is widely used for degreasing industrial metal products. TCE is designated as a Class II Specified Chemical Substance and must be controlled under the guidelines for environment conservation. TCE is known to be a carcinogen for the liver and kidney in animals (Maltoni et al., 1988; NTP, 1988 NTP, , 1990 , and long-term exposure to TCE is believed to lead to cancers in humans as well (IARC, 1995) .
The kidneys are the primary target of TCE, and nephrotoxicity is linked to metabolism of TCE via the glutathione conjugation pathway (Caldwell and Keshava, 2006; Lock and Reed, 2006; Lash et al., 2000a Lash et al., , 2000b . Once glutathione conjugate is formed, it is further metabolized to the cysteine conjugate DCVC, which is subsequently activated through α,β-elimination by the action of the cysteine conjugate β-lyase (Tateishi et al., 1987) . Thus, many mechanistic studies of TCE-induced nephrotoxicity have focused on DCVC. The toxicity of DCVC has been well characterized in various animal models, including calves, dogs, cats, rabbits, guinea pigs, turkeys, rats and mice Eyre et al., 1995; Hassall et al., 1983; Krejci et al., 1991) . With the exception of an investigation conducted by Terracini and Parker (1965) , all the above-mentioned studies were examinations on short-term exposure to DCVC. In the study conducted by Terracini and Parker, rats were administered DCVC in the drinking water for 12 weeks.
The primary target of DCVC in most animals is the renal proximal tubules (McKinney et al., 1959) . At high doses (75 mg/kg), DCVC causes acute, lethal renal failure which is characterized morphologically by intensely eosinophilic and necrotic proximal tubular epithelium with some exfoliation of cellular detritus into tubular lumens (Korrapati et al., 2005 (Korrapati et al., , 2006 (Korrapati et al., and 2007 .
Much of the current understanding of the mechanism of DCVC-induced renal injury is derived from studies on isolated proximal tubular cells, proximal tubules, renal cell lines or subcellular fractions of renal cortical homogenates from rats, rabbits and other non-human mammals. Studies using freshly isolated rat proximal tubular cells have indicated that DCVC is a potent cytotoxin, leading to primary mitochondrial dysfunction (Lash et al., 1986a) and inhibition of mitochondrial Ca 2+ sequestration (Vamvakas et al., 1992) . The importance of mitochondria in DCVC-induced nephrotoxicity is further highlighted by the studies of rabbit proximal tubules which have demonstrated that the preservation of mitochondrial function is associated with recovery and repair in damaged epithelial cells (Liu et al., 2004; Nowak et al., 1999; Nowak, 2003; Shaik et al., 2007 Shaik et al., , 2008 .
Many in vivo studies have been conducted to examine nephrotoxicity of DCVC by short-term exposure in order to elucidate mechanism of toxicity expression by shortterm exposure of TCE. However, very few subchronic and chronic studies have been implemented for toxicity expression by chronic exposure of DCVC. Thus, in the present study, exposure was determined to be performed once a week according to Vaidya et al. (2003a) suggesting that time around 120 hr was required to recover from the renal dysfunction (blood urea nitrogen (BUN), urine excretion volume, glucosuria) caused by DCVC at 15 mg/kg, and the period of the experiment was determined to be 13 weeks, same as a previous subchronic exposure study on TCE (NTP, 1990) . In addition, examination was conducted at 1 week after the last administration, assuming renal function to have been showing indications of recovery. Besides, examination on several inflammation factors was performed at 1 week after the last administration to confirm whether they continued expressing at 1 week after subchronic exposure or not.
MATERIALS AND METHODS

Materials
DCVC was synthesized from TCE and L-cysteine as described previously (McKinney et al., 1959) , with a purity of 95% or greater.
Preparation of animals
BALB/c male mice (6 weeks old) were purchased from Charles River Japan (Kanagawa, Japan). All animal experiments were approved by the Institutional Animal Care and Use Committee, and were performed according to the Guide for Animal Experimentation of Toin University of Yokohama. All procedures followed the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology. Mice assigned to the Main Study were divided into seven groups (n = 6 for the control and 10 and 30 mg/kg oral (p.o.) administration groups, and n = 7 for the 1 mg/kg p.o. and 1, 10 and 30 mg/kg intraperitoneal (i.p.) administration groups). The satellite study group (PCR Study) consisted of five mice administered with 30 mg/kg by p.o. and i.p. routes and control group consisted of five mice. All doses were prepared by dissolving DCVC in isotonic saline followed by once weekly administration to Main Study animals for 13 weeks and to the PCR Study animals for 8 weeks. Control mice received isotonic saline only. Body weight was measured on each day of dosing and at 7 days after the last dose was administered. Mice were sacrificed by vertebral luxation 7 days following the last dose and the blood was collected from the ventriculus sinister with an EDTA-treated polypropylene syringe attached with a 26-gauge stainless steel needle. The kidneys were excised, weighed and placed in neutral-buffered formalin. BUN was measured using the urease-indophenol method with a Blood Urea Test kit (Wako Pure Chemical Industries, Osaka, Japan).
Histochemistry
Kidneys were fixed with neutral-buffered formalin, processed and embedded in paraffin. Sagittal sections of kidney were stained with hematoxylin and eosin (H&E), Azan and periodic acid-methenamine-silver (PAM). Stained tissue sections were examined with a light microscope (Keyence BZ-8100, Osaka, Japan).
Real-time PCR
For the PCR Study, mRNA was examined for the mouse tumor necrosis factor-α (TNF-α), interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-6 (IL-6) and cyclooxygenase-2 (Cox-2) in the kidney by real-time polymerase chain reaction. The RNeasy Mini Kit (Qiagen K.K., Tokyo, Japan) was used to extract RNA from kidney of mouse that had been exposed to 30 mg/kg DCVC for 8 weeks. Total RNA (3 μg) was reverse transcribed using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Tokyo, Japan) with random primers in a 20 μl reaction mixture according to the manufacturer's protocols. Quantitative polymerase chain reaction analysis was performed with LightCycler 480 System II (Roche) and LightCycler 480 SYBR Green I Master (Roche). PCR (95°C for 15 sec, 60°C for 1 min, for 40 cycles) was performed using the specific primers (sense primer, 5'-AAGCCTG-TAGCCCACGTCGTA-3', and antisense primer, 5'-AGG-TACAACCCATCGGCTGG-3') for mouse TNF-α, (sense primer, 5'-CAAACTGATGAAGCTCGTCA-3', and antisense primer, 5'-TCTCCTTGAGCGCTCACGAA-3') for mouse IL-1α, (sense primer, 5'-ATGGCAACTGTTCCT-GAACTCAACT-3', and antisense primer, 5'-CAGGA-CAGGTATAGATTCTTTCCTTT-3') for mouse IL-1β, (sense primer, 5'-ACAACCACGGCCTTCCCTAC-3', and antisense primer, 5'-TCCACGATTTCCCAGA-GAACA-3') for mouse IL-6, (sense primer, 5'-TGAG-CAACTATTCCAAACCAGC-3', and antisense primer, 5'-GCACGTAGTCTTCGATCACTATC-3') for mouse Cox-2 and (sense primer, 5'-TTGTTGAGTTGGACT-CACTGT-3', and antisense primer, 5'-GCGTGTGCCA-GAAGACCA-3') for mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH was used as an internal standard for normalization of each sample.
Statistical analysis
Numerical data were expressed as means ± S.D. for groups of five, six or seven animals, and the results were analyzed by analysis of variance (ANOVA) and Dunnett's test. Statistical significance was set at P < 0.05. Experiments were repeated independently in duplicate, and the results were qualitatively identical in every case.
RESULTS
Effect of DCVC on body weight
Mice exposed to 1 and 10 mg/kg DCVC by p.o. and i.p. routes did not display a significant change in body weight gain compared to the control group exposed to isotonic saline alone. In contrast, body weight decreased by approximately 20% compared to controls one week after the first dosing to mice at 30 mg/kg DCVC. After the first week, however, the body weight in the 30 mg/kg administration groups increased in a similar manner to controls for the remainder of the administration period (Fig. 1) .
Effect of DCVC on kidney weight
Regardless of the dosing route, DCVC administration resulted in a dose-dependent decrease in kidney weight (Fig. 2) . In mice exposed to 1, 10 and 30 mg/kg DCVC, the ratio of kidney weight to body weight decreased by up to 10%, 30% and 50%, respectively, compared to the control group.
Effect of DCVC on renal function
In groups administered DCVC at 1 and 10 mg/kg p.o. and 1 mg/kg i.p., no significant changes were observed in the level of BUN compared to the control group. However, the BUN level in mice administered DCVC at 10 mg/kg i.p. was about 1.5-fold higher than in the control group and that at 30 mg/kg p.o. and i.p. was about 2-fold higher than in the control group (Fig. 3) .
Pathology
H&E, Azan and PAM-stained kidney sections of the mice administered with 1 mg/kg DCVC by p.o. and i.p. routes showed weak renal tubular dilation and no tubular necrosis, and those administered with 10 mg/kg DCVC showed mild renal tubular dilation and weak tubular necrosis (data not shown). In contrast, kidney sections revealed marked renal tubular dilation and moderate tubu- 
Real-time PCR
Real-time PCR showed that TNF-α, IL-6 and Cox-2 mRNAs were up-regulated in the kidneys of male mice administered with 30 mg/kg DCVC by p.o. and i.p. routes when compared with the control mice. IL-1α and IL-1β mRNAs, however, were undetectable with real-time PCR. mRNA expression of renal tubular inflammatory cytokines are illustrated in Fig. 5. 
DISCUSSION
DCVC, both an active metabolite of TCE and a critical factor of nephrotoxicity caused by acute exposure of TCE, have been studied on short-term exposure (Beuter et al., 1989; Lash and Anders, 1986b) . However, very few studies have been done to investigate the effect of chronic and subchronic exposure of DCVC on nephrotoxicity. Therefore, we investigated the effect of subchronic exposure of DCVC on kidney in mice to elucidate the mechanism of renal toxicity expression of TCE.
After administration of DCVC, dose-proportional decrease in the kidney weight was observed within the dose ranges including all the doses at 1, 10 and 30 mg/kg p.o. and i.p. Increase in BUN was dose-proportional within the dose ranges including p.o. and i.p. doses in all the groups except the 10 mg/kg p.o. group. The reason why the 10 mg/kg p.o. group did not show increase in BUN was not explicated. Several pathohistological observations including dilatation and necrosis of renal tubule and fibrosis of interstitium exhibited aggravation as the dose increased within the dose ranges consisting of p.o. and i.p. doses in all the groups. Comparing the findings in the present experiment with those at 1 week after acute exposure (Vaidya et al., 2003a) , BUN values at 1 mg/kg p.o. and i.p.and 10 mg/kg p.o. were equivalent, and slightly higher at 10 mg/kg i.p. Compared with the acute exposure experiments (Korrapati et al., 2005 (Korrapati et al., , 2006 (Korrapati et al., and 2007 Terracini and Parker, 1965) , pathohistological symptoms such as dilatation of renal tubule, tubular necrosis and interstitial fibrosis observed at DCVC 30 mg/kg p.o. and i.p were not markedly different. Inflammatory cytokines such as TNF-α (Sanchez-Niño et al., 2010; Navarro and Mora-Fernandez, 2006 ) and IL-6 (Nechemia-Arbely et al., 2008) participate in acute kidney injury. It was also reported that plasma IL-6 pro- tein and renal IL-6 mRNA of mouse increased markedly as early as 1 hr after dosing of DCVC (75 mg/kg, i.p.) (Vaidya et al., 2003b (Vaidya et al., , 2003c . However, there is no report whether subchronic exposure of mouse to DCVC affects enhancement of inflammatory cytokines, such as TNF-α, IL-6 and IL-1, in the kidney. Our results showed that TNF-α and IL-6 mRNAs were up-regulated in the kidney treated with 30 mg/kg DCVC for 8 weeks. Furthermore, we found that Cox-2 mRNA increased in mouse kidney treated with DCVC. Cox-2 that catalyzes the committed step in the synthesis of prostaglandins (Vane, 1971) thereby promoted inflammatory response and Cox-2 expression is induced by pro-inflammatory stimuli (Needleman and Isakson, 1997) . The results indicated that DCVCinduced kidney damage might be induced by up-regulation of inflammatory cytokines and by the following Cox-2 expression. Almost the same results after p.o. and i.p. administrations suggested that DCVC was absorbed in intestinal tract and distributed to liver and systemic circulation before expression of toxicity in kidney. This coincide with the pharmacokinetic disposition of TCE which have already been reported that exposed TCE is absorbed in intestinal tract, partially changed into glutathione conjugate in liver and transformed into DCVC in bile duct or intestinal tract. Subsequently, DCVC is reabsorbed in intestinal tract and transformed into active thiol by cysteine conjugate β-lyase in liver and kidney, and then the generated active thiol expresses toxicity in kidney (Dekant et al., 1987 . The active thiol is chemically unstable, with higher reactivity than other thiols, which means thiols generated in other organs can hardly act in kidney via systemic circulation. Thus, thiols generated by the action of cysteine conjugate β-lyase localized in kidney are considered to have expressed renal toxicity Tateishi, 1990, 1992) . For example, hexafluoropropene is considered that its metabolites generated in kidney only express nephrotoxicity, since hexafluoropropene is metabolized in different manner in liver and kidney .
After 12 weeks of administration of 0.01% DCVC solution (equivalent as 10 mg/kg/day) to rats, according to Terracini and Parker (1965) , pathohistological observations of hypertrophy of nuclei in proximal renal tubule and dilatation of renal tubule are observed. In the present experiment in mice, the same symptoms were observed, whereas the extent was slighter than those in rats. Although species differences, it was demonstrated that the damage in renal tubule increased with the extent of DCVC exposure. Besides, DCVC have been reported that it triggers cytotoxicity bringing malfunction of mitochondria in renal tubule epithelocytes in in vitro system. From the above knowledge and the present results, disability of cells developed by DCVC is inferred to cause hypertrophy of nuclei.
In conclusion, our results indicate that subchronic exposure to DCVC causes tubular degeneration in male mice characterized by tubular necrosis and interstitial fibrosis, with increased blood levels of urea nitrogen, and that the degradation symptoms increase with the total exposure of DCVC. Degenerative changes were accompanied by up-regulation of several inflammatory cytokines that may contribute to the degenerative process. Chronic exposure of DCVC is required to further elucidate nephrotoxicity exhibited by TCE.
